Skip to search formSkip to main contentSkip to account menu

BRL 26830A

Known as: BRL 26830, BRL-26830A, Benzoic acid, 4-(2-((2-hydroxy-2-phenylethyl)amino)propyl)-, methyl ester, (R*,R*)-(+-)-, (E)-2-butenedioate (2:1) (salt) 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Adrenergic beta-AgonistsEthanolaminesHypoglycemic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice.
The anti-obesity and anti-diabetic actions of BRL 26830A, beta 3-adrenoceptor agonist, (2 mg/kg administered intramuscularly… 
1990
1990
Mitigation of obesity by BRL 26830A, a new beta-adrenoceptor agonist, in MSG obese mice.
Half of the mice in both the monosodium-L-glutamate (MSG)-induced obesity and saline control groups were given BRL 26830A via a… 
1988
1988
The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity.
Beta-adrenoceptor agonists have recently been shown to promote substantial loss of adipose tissue in laboratory animals. One of… 
1988
1988
Acute effects of a beta-adrenoceptor agonist (BRL 26830A) on rat brown-adipose-tissue mitochondria. Increased GDP binding and GDP-sensitive proton conductance without changes in the concentration of…
GDP binding, proton conductance and the specific concentration of uncoupling protein were measured in brown-adipose-tissue… 
1988
1988
Effect of a thermogenic agent, BRL 26830A, on insulin receptors in obese mice.
The effect of a new type of antidiabetic agent, BRL 26830A, has been tested in obese mice. Since this drug increases… 
1985
1985
Increased insulin binding and glucose transport in white adipocytes isolated from C57B1/6 ob/ob mice treated with the thermogenic beta-adrenoceptor agonist BRL 26830.
1985
1985
Improved Glycemic Control in C57BI/KsJ (db/db) Mice After Treatment with the Thermogenic β-Adrenoceptor Agonist, BRL 26830
BRL 26830, (R*,R*)-(±)-methyl-4-(2-[{2-hydroxy-2-phenylethyl} amino]propyl)-benzoate, is a new type of β-adrenoceptor receptor… 
1985
1985
Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.
1985
1985
Effect of a novel thermogenic beta-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats.
1984
1984
Genetically obese C57BL/6 ob/ob mice respond normally to sympathomimetic compounds.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)